Australia markets open in 1 hour 7 minutes

Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
17.86+0.85 (+5.00%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
270,916
269,856
373,878
283,248
200,238
Cost of revenue
142,054
135,682
177,271
107,979
74,352
Gross profit
128,862
134,174
196,607
175,270
125,886
Operating expenses
Research development
59,355
58,404
64,468
55,048
37,722
Selling general and administrative
54,403
53,320
54,113
46,505
40,233
Total operating expenses
124,976
121,760
127,085
111,760
79,360
Operating income or loss
3,886
12,414
69,523
63,509
46,526
Interest expense
-
585.0831
881.7023
132.1921
0
Income before tax
9,772
21,976
79,947
69,644
51,727
Income tax expense
3,361
3,531
261.1082
6,114
3,341
Income from continuing operations
6,411
18,445
79,686
63,530
48,386
Net income
7,967
19,669
79,686
63,530
48,386
Net income available to common shareholders
7,967
19,669
79,686
63,530
48,386
Basic EPS
0.37
0.18
0.74
0.58
0.46
Diluted EPS
0.35
0.17
0.71
0.58
0.46
Basic average shares
125,644
109,272
107,684
108,669
105,939
Diluted average shares
132,281
115,700
112,234
108,669
105,939